JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB273297

Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric)

3

(2 Reviews)

|

(18 Publications)

Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit ab273373 uses the ability of an active ACE2 to cleave a synthetic MCA based peptide substrate to release a free fluorophore.

View Alternative Names

UNQ868/PRO1885, ACE2, Angiotensin-converting enzyme 2, Angiotensin-converting enzyme homolog, Angiotensin-converting enzyme-related carboxypeptidase, Metalloprotease MPROT15, ACEH, ACE-related carboxypeptidase

4 Images
Functional Studies - Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric) (AB273297)
  • FuncS

Supplier Data

Functional Studies - Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric) (AB273297)

Typical standard curve – data provided for demonstration purposes only. A new standard curve must be generated for each assay performed.

MCA Standard Curve (0-300 pmol), error bars indicate SD (n=3).

Functional Studies - Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric) (AB273297)
  • FuncS

Supplier Data

Functional Studies - Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric) (AB273297)

Spiked ACE2 activity and inhibition measured in HEK-293 cell lysate (total protein : 37 μg).

Functional Studies - Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric) (AB273297)
  • FuncS

Supplier Data

Functional Studies - Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric) (AB273297)

Kinetic activity curves using different amounts of ACE2 Positive Control in the assay.

Functional Studies - Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric) (AB273297)
  • FuncS

Supplier Data

Functional Studies - Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric) (AB273297)

ACE2 Activity in Tissue Samples.

ACE2 activity was measured for different types of rat tissue samples (total protein in lung and kidney; 17 μg and 23 μg respectively), and human kidney tissue sample (10 μg total protein) in presence (+ Inhibitor) and absence (- Inhibitor) of ACE2 Inhibitor.

Key facts

Detection method

Fluorescent

Sample types

Tissue, Suspension cells, Adherent cells

Assay type

Enzyme activity

Results type

Quantitative

Sensitivity

= 400 µU

Assay Platform

Microplate

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Enzyme activity assay": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric) (ab273373) uses the ability of active ACE2 to cleave a synthetic MCA based peptide substrate to release a free fluorophore. The released MCA can be easily quantified using a fluorescence microplate reader.

The kit also includes an ACE2 specific inhibitor that can differentiate the ACE2 activity from other proteolytic activity. The kit can detect as low as 0.4 mU. The assay kit is simple and can be used in a high-throughput format.

A negative control should be run for each sample to differentiate ACE2 activity from other proteolytic activity in your sample

Other Notes
This product was previously called K897 Biovision Angiotensin II Converting Enzyme (ACE2) Activity Assay Kit (Fluorometric). Biovision was acquired by Abcam in 2021.

The Safety Datasheet for this product has been updated for certain countries. Please check the current version in the Support and downloads section.

What's included?

{ "values": { "100Test": { "sellingSize": "100 Test", "publicAssetCode":"ab273297-100Test", "assetComponentDetails": [ { "size":"1 x 50 µL", "name":"ACE2 Inhibitor", "number":"AB273297-CMP08", "productcode":"" }, { "size":"1 x 200 µL", "name":"ACE2 Substrate", "number":"AB273297-CMP02", "productcode":"" }, { "size":"1 x 50 mL", "name":"ACE2 Lysis Buffer", "number":"AB273297-CMP06", "productcode":"" }, { "size":"1 x 1.5 mL", "name":"ACE2 Dilution Buffer", "number":"AB273297-CMP04", "productcode":"" }, { "size":"1 x 20 µL", "name":"ACE 2 Enzyme", "number":"AB273297-CMP01", "productcode":"" }, { "size":"1 x 25 µL", "name":"MCA Standard", "number":"AB273297-CMP07", "productcode":"" }, { "size":"1 x 25 mL", "name":"Assay Buffer 11", "number":"AB273297-CMP03", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The ACE2 protein also known as angiotensin-converting enzyme 2 is an essential component in the renin-angiotensin system. It functions mechanically by converting the hormone angiotensin II to angiotensin-(1-7) which helps regulate blood pressure and fluid balance. The molecular weight of ACE2 is approximately 120 kDa. This protein is expressed in various tissues particularly the lungs heart kidneys and gastrointestinal tract. In cultured cells like Caco-2 cells researchers often study this expression.
Biological function summary

The ACE2 protein plays an important role in the regulation of cardiovascular and renal functions. It is a single-pass type I membrane protein and its activity reduces inflammation and oxidative stress in cells. ACE2 does not function as part of a larger protein complex but its enzymatic conversion has a substantial impact on reducing the effects of angiotensin II in the body leading to vasodilation and decreased blood pressure.

Pathways

ACE2 involvement is significant in the renin-angiotensin system and the kallikrein-kinin system. These pathways are essential for maintaining cardiovascular homeostasis. In the renin-angiotensin system ACE2 works in opposition to angiotensin-converting enzyme (ACE) balancing the effects through the production of angiotensin-(1-7) from angiotensin II. Additionally ACE2 interacts indirectly with proteins like angiotensin receptor type 1 (AT1) and angiotensin receptor type 2 (AT2) ensuring proper signaling and physiological responses.

ACE2 links closely with conditions such as hypertension and COVID-19. Increased activity of angiotensin II due to low ACE2 levels contributes to hypertension. In infectious disease SARS-CoV-2 virus responsible for COVID-19 uses ACE2 as an entry receptor to initiate infection in host cells. This interaction highlights the importance of ACE2 in disease pathogenesis and has prompted interest in ACE2 as a potential therapeutic target.

Product protocols

Target data

Essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis (PubMed : 27217402). Converts angiotensin I to angiotensin 1-9, a nine-amino acid peptide with anti-hypertrophic effects in cardiomyocytes, and angiotensin II to angiotensin 1-7, which then acts as a beneficial vasodilator and anti-proliferation agent, counterbalancing the actions of the vasoconstrictor angiotensin II (PubMed : 10924499, PubMed : 10969042, PubMed : 11815627, PubMed : 14504186, PubMed : 19021774). Also removes the C-terminal residue from three other vasoactive peptides, neurotensin, kinetensin, and des-Arg bradykinin, but is not active on bradykinin (PubMed : 10969042, PubMed : 11815627). Also cleaves other biological peptides, such as apelins (apelin-13, [Pyr1]apelin-13, apelin-17, apelin-36), casomorphins (beta-casomorphin-7, neocasomorphin) and dynorphin A with high efficiency (PubMed : 11815627, PubMed : 27217402, PubMed : 28293165). In addition, ACE2 C-terminus is homologous to collectrin and is responsible for the trafficking of the neutral amino acid transporter SL6A19 to the plasma membrane of gut epithelial cells via direct interaction, regulating its expression on the cell surface and its catalytic activity (PubMed : 18424768, PubMed : 19185582).. (Microbial infection) Acts as a receptor for human coronaviruses SARS-CoV and SARS-CoV-2, as well as human coronavirus NL63/HCoV-NL63.. Isoform 2. Non-functional as a carboxypeptidase.. Isoform 2. (Microbial infection) Non-functional as a receptor for human coronavirus SARS-CoV-2.
See full target information ACE2

Publications (18)

Recent publications for all applications. Explore the full list and refine your search

International journal of biological sciences 21:3901-3916 PubMed40607249

2025

Epithelial DPP4 promotes Ang II-driven renal fibrosis by targeting ACE2 activity in the renin-angiotensin system.

Applications

Unspecified application

Species

Unspecified reactive species

Yingying Zhang,Ruizhi Tan,Lehao Wu,Dan Zhao,Cheng Zhong,Chenggong Luo,Jeff Yat-Fai Chung,Patrick Ming-Kuen Tang,Chen Yu

Journal of cellular and molecular medicine 28:e70228 PubMed39622780

2024

Geraniin Alleviates Mouse Laser-Induced Choroidal Neovascularisation by Inhibiting Choroidal Endothelial Cell ACE2/Ang-(1-7)/MasR/IL-10 Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hongyi Lu,Qi Cai,Lele Li,Jiayi Gu,Yuting Zhang,Haotian Sun,Hui Su,Lei Song

Fundamental & clinical pharmacology 38:1143-1154 PubMed39128482

2024

Alamandin and especially melatonin attenuate pulmonary arterial hypertension induced by monocrotalin.

Applications

Unspecified application

Species

Unspecified reactive species

Seyhan Ayik,Mehmet Gunata,Onural Ozhan,Azibe Yildiz,Nigar Vardi,Emre Sonmez,Necip Ermis,Nilay Ates,Ertugrul Kilic,Samir Abbas Ali Noma,Ahmet Ulu,Seyfullah Taha Inan,Haci Ahmet Acet,Hakan Parlakpinar

Frontiers in veterinary science 11:1362379 PubMed38756510

2024

Urinary angiotensin-converting enzyme 2 and its activity in cats with chronic kidney disease.

Applications

Unspecified application

Species

Unspecified reactive species

Tzu-Chien Kuo,Wei-Li Hsu,Vin-Cent Wu,Tong-Rong Jan,Pei-Shiue Jason Tsai,Ya-Jane Lee

Signal transduction and targeted therapy 9:104 PubMed38654010

2024

FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Meng,Zhiying Liao,Yanting Ji,Dong Wang,Yang Han,Chaolin Huang,Xujuan Hu,Jingyi Chen,Hengrui Zhang,Zonghong Li,Changliang Wang,Hui Sun,Jiaqi Sun,Lihua Chen,Jiaxiang Yin,Jincun Zhao,Tao Xu,Huisheng Liu

mBio 15:e0054124 PubMed38501835

2024

ACE-2-like enzymatic activity is associated with immunoglobulin in COVID-19 patients.

Applications

Unspecified application

Species

Unspecified reactive species

Yufeng Song,Regan Myers,Frances Mehl,Lila Murphy,Bailey Brooks,Jeffrey M Wilson,Alexandra Kadl,Judith Woodfolk,Steven L Zeichner

Journal of virology 98:e0010224 PubMed38470058

2024

ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.

Applications

Unspecified application

Species

Unspecified reactive species

Miriam Ruth Heindl,Anna-Lena Rupp,Marie Schwerdtner,Dorothea Bestle,Anne Harbig,Amy De Rocher,Luna C Schmacke,Bart Staker,Torsten Steinmetzer,David A Stein,Hong M Moulton,Eva Böttcher-Friebertshäuser

Pharmacological research 196:106920 PubMed37716548

2023

Genetically engineered Lactobacillus paracasei rescues colonic angiotensin converting enzyme 2 (ACE2) and attenuates hypertension in female Ace2 knock out rats.

Applications

Unspecified application

Species

Unspecified reactive species

Xue Mei,Blair Mell,Sachin Aryal,Ishan Manandhar,Ramakumar Tummala,Jasenka Zubcevic,Khanh Lai,Tao Yang,Qiuhong Li,Beng San Yeoh,Bina Joe

Nature communications 14:3680 PubMed37369668

2023

In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting.

Applications

Unspecified application

Species

Unspecified reactive species

Wen Juan Tu,Michelle Melino,Jenny Dunn,Robert D McCuaig,Helle Bielefeldt-Ohmann,Sofiya Tsimbalyuk,Jade K Forwood,Taniya Ahuja,John Vandermeide,Xiao Tan,Minh Tran,Quan Nguyen,Liang Zhang,Andy Nam,Liuliu Pan,Yan Liang,Corey Smith,Katie Lineburg,Tam H Nguyen,Julian D J Sng,Zhen Wei Marcus Tong,Keng Yih Chew,Kirsty R Short,Roger Le Grand,Nabila Seddiki,Sudha Rao

Nature 615:134-142 PubMed36470304

2022

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.

Applications

Unspecified application

Species

Unspecified reactive species

Teresa Brevini,Mailis Maes,Gwilym J Webb,Binu V John,Claudia D Fuchs,Gustav Buescher,Lu Wang,Chelsea Griffiths,Marnie L Brown,William E Scott,Pehuén Pereyra-Gerber,William T H Gelson,Stephanie Brown,Scott Dillon,Daniele Muraro,Jo Sharp,Megan Neary,Helen Box,Lee Tatham,James Stewart,Paul Curley,Henry Pertinez,Sally Forrest,Petra Mlcochova,Sagar S Varankar,Mahnaz Darvish-Damavandi,Victoria L Mulcahy,Rhoda E Kuc,Thomas L Williams,James A Heslop,Davide Rossetti,Olivia C Tysoe,Vasileios Galanakis,Marta Vila-Gonzalez,Thomas W M Crozier,Johannes Bargehr,Sanjay Sinha,Sara S Upponi,Corrina Fear,Lisa Swift,Kourosh Saeb-Parsy,Susan E Davies,Axel Wester,Hannes Hagström,Espen Melum,Darran Clements,Peter Humphreys,Jo Herriott,Edyta Kijak,Helen Cox,Chloe Bramwell,Anthony Valentijn,Christopher J R Illingworth,Bassam Dahman,Dustin R Bastaich,Raphaella D Ferreira,Thomas Marjot,Eleanor Barnes,Andrew M Moon,Alfred S Barritt,Ravindra K Gupta,Stephen Baker,Anthony P Davenport,Gareth Corbett,Vassilis G Gorgoulis,Simon J A Buczacki,Joo-Hyeon Lee,Nicholas J Matheson,Michael Trauner,Andrew J Fisher,Paul Gibbs,Andrew J Butler,Christopher J E Watson,George F Mells,Gordon Dougan,Andrew Owen,Ansgar W Lohse,Ludovic Vallier,Fotios Sampaziotis
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com